Success Stories: Our Skilled Team Helped A Postdoctoral Fellow from India Obtain the EB-2 NIW Petition Approval Without RFE

Client’s Testimonial:

“I had a great experience working with the Chen Immigration attorney and team.”

On December 14^th, 2020, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Oncology (Approval Notice).

General Field: Oncology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: India

Country of Residence at the Time of Filing: India

Approval Notice Date: December 14^th, 2020

Processing Time: 7 months, 23 days

Case Summary:

A postdoctoral fellow based in India approached North America Immigration Law Group to aid him in building an EB-2 NIW (National Interest Waiver) petition on his behalf. With a Ph.D. in biochemistry and molecular biology and researching the field of oncology, our client was eligible for the NIW visa category. Once we declared that we could head our client to the EB-2 victory, we made certain of all the required testimonies. To fortify his case, we incorporated the following details in our EB-2 NIW petition:

Research Outline: Our purpose was to attest to the USCIS that our client is erudite in his field and we detailed his research focusing on the pathophysiology and underlying mechanisms of pancreatic cancer and related diseases in order to improve clinical outcomes and enhance the therapeutic efficacy of treatment techniques for cancer patients. This kind of research has great importance because it accelerates the development of targeted treatment techniques to improve the prognosis of cancer patients in countries throughout the world. We were certain that his insightful research work will benefit the healthcare industry in the United States, and help him secure the national interest waiver petition approved by the USCIS.
Peer- Review Experience, Publication, and Citation Count: We demonstrated further that our client not only successfully finished his research, but his work also influenced his peers and acquaintances. According to Google Scholar, his publications have been cited 222 times and have been among the most-referred, establishing that our client’s publications are widely acknowledged in the field of oncology.
Furthermore, we specified the 11 peer-reviewed journal articles (2 of them first-authored or co-first-authored) and 1 first-authored book chapter, and validating his expertise in the field, we recorded that he had already conducted 10 reviews at the time of filing the petition.
Consolidating Recommendation Letters: To corroborate all the attached documents, we advised our client to garner a few recommendation letters, and based on our advice, our client managed to secure 5 recommendation letters indicating our client’s invaluable research work and consisted of statements like:

“[Our client] has set the grounds for the development of more targeted pharmaceuticals for pancreatic cancer patients. His findings are vital to ongoing research on anticancer treatments and methodologies, and his work has helped reduce the overall burden of cancer spending in the United States and worldwide.”

“As his research indicates, [our client] is an indispensable member of the medical research community, and his work has indisputable benefits to the American population..”

As we presented a strong case to the USCIS, within 8months our client got the NIW petition approval. We sincerely congratulate him to qualify for the EB-2 visa category and, we thank him for trusting our law firm for this opportunity.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.